Afficher la notice abrégée

dc.contributor.authorLaurent-Rolle, Maudry
dc.contributor.authorMorrison, Juliet
dc.contributor.authorRajsbaum, Ricardo
dc.contributor.authorMacleod, Jesica M. Levingston
dc.contributor.authorPisanelli, Giuseppe
dc.contributor.authorPham, Alissa
dc.contributor.authorAyllón Barasoain, Juan 
dc.contributor.authorMiorin, Lisa
dc.contributor.authorMartínez Romero, Carles
dc.contributor.authortenOever, Benjamin R.
dc.contributor.authorGarcía Sastre, Adolfo
dc.date.accessioned2024-09-04T12:21:05Z
dc.date.available2024-09-04T12:21:05Z
dc.date.issued2014-09
dc.identifier.issn1931-3128
dc.identifier.urihttp://hdl.handle.net/10259/9529
dc.description.abstractTo successfully establish infection, flaviviruses have to overcome the antiviral state induced by type I interferon (IFN-I). The nonstructural NS5 proteins of several flaviviruses antagonize IFN-I signaling. Here we show that yellow fever virus (YFV) inhibits IFN-I signaling through a unique mechanism that involves binding of YFV NS5 to the IFN-activated transcription factor STAT2 only in cells that have been stimulated with IFN-I. This NS5-STAT2 interaction requires IFN-I-induced tyrosine phosphorylation of STAT1 and the K63-linked polyubiquitination at a lysine in the N-terminal region of YFV NS5. We identified TRIM23 as the E3 ligase that interacts with and polyubiquitinates YFV NS5 to promote its binding to STAT2 and trigger IFN-I signaling inhibition. Our results demonstrate the importance of YFV NS5 in overcoming the antiviral action of IFN-I and offer a unique example of a viral protein that is activated by the same host pathway that it inhibits.en
dc.description.sponsorshipThese studies were partly supported by NIAID grant U54AI057158 (to A.G.-S.) and by NIH fellowship FAI077333A (to M.L.-R.). We thank Richard Cadagan and Osman Lizardo for technical assistance, and Dr. Adriana Forero for editorial help. Confocal laser scanning microscopy was performed at ISMMS-Microscopy Shared Resource facility.en
dc.format.mimetypeapplication/pdf
dc.language.isoenges
dc.publisherCell Pressen
dc.relation.ispartofCell Host & Microbe. 2014, V. 16, n. 3, p. 314-327es
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subject.otherMedicinaes
dc.subject.otherMedicineen
dc.subject.otherSaludes
dc.subject.otherHealthen
dc.subject.otherMicrobiologíaes
dc.subject.otherMicrobiologyen
dc.subject.otherEnfermedades infecciosases
dc.subject.otherCommunicable diseasesen
dc.titleThe Interferon Signaling Antagonist Function of Yellow Fever Virus NS5 Protein Is Activated by Type I Interferonen
dc.typeinfo:eu-repo/semantics/articlees
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses
dc.relation.publisherversionhttps://doi.org/10.1016/j.chom.2014.07.015es
dc.identifier.doi10.1016/j.chom.2014.07.015
dc.relation.projectIDinfo:eu-repo/grantAgreement/NIAID//U54AI057158/US/es
dc.relation.projectIDinfo:eu-repo/grantAgreement/NIH//FAI077333A/US/es
dc.journal.titleCell Host & Microbeen
dc.volume.number16es
dc.issue.number3es
dc.page.initial314es
dc.page.final327es
dc.type.hasVersioninfo:eu-repo/semantics/acceptedVersiones


Fichier(s) constituant ce document

Thumbnail

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée